EMEA-001652-PIP01-14-M03
Key facts
| Invented name |
Reagila
|
| Active substance |
Cariprazine (hydrochloride)
|
| Therapeutic area |
Psychiatry
|
| Decision number |
P/0105/2021
|
| PIP number |
EMEA-001652-PIP01-14-M03
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Treatment of schizophrenia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
|
| Decision type |
RPM: decision refers to a refusal on the application for modification of an agreed PIP
|